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Inflammatory diseases of unknown causes are difficult to treat, although non-steroidal 
anti-inflammatory drugs (NSAIDs) are anticipated to be useful drugs. It was believed 
that bioactive compounds isolated from plants might have potential anti-inflammatory 
properties without any side effects. Therefore, the main objectives of this study were to 
evaluate the effects of selected phytochemicals from Malaysian plants on the production 
of main inflammatory mediators and to study their mechanism of action in cellular 
models of inflammation.  
Through the preliminary study, four out of the 32 phytochemicals tested were selected.  
They were atrovirinone, cardamonin, flavokawain B and zerumbone, which were 
isolated from Garcinia atroviridis, Alpinia rafflesiana, Alpinia zerumbet and Zingiber 
zerumbet respectively. All four compounds inhibited the release of interferon-γ (IFN-γ)/ 
lipopolysaccharide (LPS)-induced nitric oxide (NO) in macrophages cell line (RAW 
264.7) without any cytotoxicity effect, which was measured using the Griess assay. In 
order to determine the mechanism of action of these compounds, further study on the 
 iii
production of main inflammatory mediators were conducted using several bioassays, 
namely oxidative stress assay, prostaglandin E2 (PGE2) and thromboxane B2 (TxB2) 
radioimmunoassay, and cytokines (tumour necrosis factor-α; TNF-α, interleukin (IL)-
1β, IL-6 and IL-10) immunoassays. For the regulation and mechanism studies, the four 
compounds were tested on the main signaling pathways, which were the extracellular 
signal-regulated kinases (ERKs) and p38 MAPK pathways.   
The results showed that atrovirinone, cardamonin, flavokawin B and zerumbone 
significantly suppressed IFN-γ/LPS-induced NO production dose-dependently with IC50 
value of 4.62 μM, 11.40 μM, 16.33 μM and 7.70 μM respectively and inhibited the 
reactive oxygen species (ROS) generation with IC50 value of 9.48 μM, 6.48 μM, 28.16 
μM and 12.86 μM respectively. These attenuations were believed to be the result of the 
perturbation of the inducible nitric oxide synthase (iNOS) enzyme expression in 
RAW264.7 cells. The data also suggested that all four compounds exhibited anti-
inflammatory properties by selectively attenuating COX-2 activation, thus inhibiting the 
production of prostaglandin E2 (PGE2) with IC50 value of 10.31 μM, 26.18 μM, 10.32 
μM and 36.20 μM respectively in human whole blood cells. On the other hand, the ratio 
of IC50 of COX-2/COX-1, which are associated with the production of thromboxane B2 
(TxB2) in caprine whole blood cells, demonstrated that flavokawain B (ratio; 0.24 ± 
0.08) was the most selective towards the COX-2 enzyme, followed by atrovirinone 
(ratio; 0.32 ± 0.09), cardamonin (ratio; 0.42 ± 0.07) and zerumbone (ratio; 0.72 ± 0.17). 
Interestingly, three of the compounds, namely atrovirinone, cardamonin and 
zerumbone, have a dual COX/LOX inhibitory activity. In addition, cardamonin, 
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flavokawain B and zerumbone showed significant inhibition on the synthesis of TNF-α, 
IL-1β, IL-6 and IL-10 in RAW 264.7 cells in a dose-dependent manner. In contrast, 
atrovirinone significantly reduced the synthesis of pro-inflammatory cytokines, namely 
TNF-α, IL-1β and IL-6 while it increased the secretion of the anti-inflammatory 
cytokine, IL-10. It is interesting to note that all four compounds suppressed the 
phosphorylation of the mitogen-activated protein kinases (MAPKs), namely 
extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and p38 MAPK.  
Furthermore, it was hypothesized that the unique chemical structures of these 
phytochemicals are the main cause for their varying degrees in anti-inflammatory 
activities. In this study, two chalcone derivatives, namely cardamonin and flavokawain 
B were tested. The results demonstrated that substitution on the B ring was not essential 
for the anti-inflammatory activity of these chalcones. Besides, the presence of one or 
more hydroxylated and methoxylated benzoyl ring in the chalcones might enhance their 
scavenging and lipophilicity activities respectively. Similarly, it was suggested that the 
prenylated benzoquinone skeleton in atrovirinone might be important for its anti-
inflammatory effect, which is due to the fact that compounds with prenylated chemical 
entities as part of their backbone structure are usually more hydrophobic than the non-
prenylated compounds for easy penetration into the cell membrane. While in 
zerumbone, the α,β–unsaturated carbonyl group moiety might be important for its anti-
inflammatory and antioxidant effect, which could induce the detoxification enzymes 
and neutralize the lipid peroxidation.  
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In conclusion, these findings have shown that the inhibition of main inflammatory 
mediators production in the cellular models of inflammation might be due to the 
attenuation of the ERK1/2 and p38 signaling pathways. Thus, this study has 
demonstrated that atrovirinone, cardamonin, flavokawain B, and zerumbone are 
potential lead compounds for the discovery of a new generation of drugs for controlling 
various acute and chronic inflammatory diseases.  
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Institut:  Biosains 
 
Penyakit keradangan yang berpunca daripada sesuatu yang tidak diketahui adalah 
sangat sukar dirawat, meskipun ubat anti-keradangan tanpa steroid telah diperkenalkan 
bagi merawat penyakit berkenaan.  Dipercayai bahawa sebatian kimia yang berasal 
daripada tumbuh-tumbuhan mempunyai kesan anti-keradangan dan tidak menyebabkan 
sebarang kesan sampingan. Oleh itu, kajian ini bertujuan untuk menguji kesan sebatian 
kimia yang berasal daripada tumbuhan terpilih terhadap bahan perantara keradangan 
yang utama serta kesannya terhadap mekanisma keradangan.  
Melalui kajian penyaringan, empat daripada 32 sebatian kimia yang diuji telah dipilih. 
Empat sebatian kimia tersebut ialah atrovirinone, cardamonin, flavokawain B dan 
zerumbone yang telah dipencilkan daripada tumbuhan Garcinia atroviridis, Alpinia 
rafflesiana, Alpinia zerumbet dan Zingiber zerumbet masing-masing. Keempat-empat 
sebatian kimia tersebut merencat pengeluaran nitrik oksida (NO) yang di ransang oleh 
IFN-γ/LPS daripada sel makrofaj (RAW 264.7) tanpa sebarang kesan toksik melalui 
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ujian Griess asai. Bagi mengenalpasti mekanisma tindakan sebatian-sebatian kimia ini, 
kajian lanjut ke atas pengeluaran bahan perantara keradangan telah dijalankan, 
menggunakan beberapa bioasai iaitu asai tekanan oksidatif (ROS), prostaglandin E2 
(PGE2), thromboxane B2 (TxB2), dan cytokine (TNF-α, IL-1β, IL-6 dan IL-10). Di 
samping itu, sebatian-sebatian kimia ini juga diuji dari segi kesannya terhadap tapak 
jalan berisyarat utama yang terdiri daripada ERK dan p38.  
Daripada kajian yang telah dijalankan, didapati atrovirinone, cardamonin, flavokawain 
B dan zerumbone merencat pengeluaran NO dengan nilai perencatan pada kadar 50% 
(IC50) seperti berikut, iaitu 4.62 μM, 11.40 μM, 16.33 μM dan 7.70 μM masing-masing. 
Keempat-empat sebatian kimia ini juga berjaya menurunkan kadar oksigen radikal 
bebas (ROS) dengan nilai IC50 iaitu 9.48 μM, 6.48 μM, 28.16 μM dan 12.86 μM 
masing-masing. Dijangkakan bahawa perencatan ini adalah disebabkan oleh kesan 
sebatian-sebatian kimia ini terhadap enzim iNOS. Kajian ini juga telah membuktikan 
bahawa keempat-empat sebatian kimia ini telah menurunkan kadar pengeluaran PGE2 
dengan nilai IC50 iaitu 10.31 μM, 26.18 μM, 10.32 μM dan 36.20 μM masing-masing. 
Manakala, melalui nilai nisbah IC50 COX-2/COX-1 yang terhasil daripada perencatan 
pengeluaran TxB2, mendapati bahawa flavokawain B (nisbah; 0.24 ± 0.08) adalah lebih 
cenderung merencat enzim COX-2 berbanding COX-1, diikuti dengan atrovirinone 
(nisbah; 0.32 ± 0.09), cardamonin (nisbah; 0.42 ± 0.07) dan zerumbone (nisbah; 0.72 ± 
0.17). Apa yang mengkagumkan daripada kajian ini ialah tiga daripada sebatian kimia 
ini, iaitu atrovirinone, cardamonin dan zerumbone berjaya merencat kedua-dua enzim 
COX-2 dan LOX. Selain itu, cardamonin, flavokawain B dan zerumbone telah 
menunjukkan kesan perencatan ke atas pengeluaran TNF-α, IL-1β, IL-6 dan IL-10. 
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Sebaliknya, atrovirinone telah menurunkan pengeluaran cytokine pro-keradangan 
(TNF-α, IL-1β, IL-6) dan pada masa yang sama telah meningkatkan pengeluaran 
cytokine anti-keradangan iaitu IL-10. Lebih menarik lagi, keempat-empat sebatian 
kimia ini didapati merencat tindak balas fosforilasi protein MAPK iaitu ERK 1/2 dan 
p38.  
Tambahan pula, dijangkakan  bahawa perbezaan kesan anti-keradangan di antara 
sebatian-sebatian kimia ini adalah di sebabkan oleh bentuk struktur kimianya yang unik. 
Dalam kajian ini, dua sebatian kimia daripada kumpulan chalcone telah diuji, iaitu 
cardamonin dan flavokawain B. Keputusan kajian telah membuktikan bahawa ketiadaan 
unsur kimia (substitution) pada gelang B kumpulan ini tidak menjejaskan aktiviti anti-
keradangannya. Selain itu, kehadiran satu atau lebih hidroksi dan metoksi pada gelang 
benzene berkemungkinan memberi kesan kepada aktiviti kumpulan chalcone in untuk 
memerangkap radikal bebas (scavenging) dan tindakbalas dengan lipid (lipophilicity). 
Begitu juga dengan atrovirinone, dijangkakan struktur benzoquinone yang berprenyl 
adalah sangat penting bagi meningkatkan kesan anti-keradangannya. Ini disahkan 
dengan fakta yang menyatakan bahawa sebatian kimia yang mempunyai struktur 
sedemikian, pada kebiasaannya adalah lebih hidrofobik bagi memudahkan 
penyerapannya melalui membran sel. Manakala, zerumbone yang mempunyai struktur 
kumpulan α,β-karbonil tak tepu berkemungkinan sangat penting bagi meningkatkan 
kesan anti-keradangan dan anti-penuaan, di mana kumpulan struktur ini dapat 
menyahtoksikkan enzim dan meneutralkan tindakbalas pengoksidaan lipid.      
 ix
Kesimpulannya, kajian ini telah menunjukkan bahawa perencatan sintesis bahan 
perantara yang utama dalam model sel keradangan adalah mungkin disebabkan oleh 
perencatan tapak jalan ERK 1/2 dan p38. Oleh itu, kajian ini telah membuktikan 
bahawa atrovirinone, cardamonin, flavokawain B dan zerumbone mempunyai potensi 
sebagai bahan sebatian kimia utama bagi penemuan dadah generasi baru yang boleh 
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degradated by the 26S proteasome (26S). Activated NF-κB can pass  
the nuclear membrane and interact with κB binding sequences in  
enhancers of NF-κB regulated genes. LPS, lipopolysaccharide;  
ROS, reactive oxygen species; FasL, Fas ligand; TRAF, TNF-α  
receptor associated factor; NIK, NF-κB inducing kinase; MEKK,  
mitogen activated protein kinase/extracellular signal regulated  




2.17 Chemical structure of specific inhibitor of ERK (PD98059) and  
p38 MAPK (SB203580)                        48 
 
2.18 Mitogen-activated protein kinase (MAPK) signal transduction  
pathways. The triple amino acid phosphorylation motif Thr-X-Tyr  
(T-X-Y) depends on the MAPK isoform, where X is glutamic acid  
(E) for extracellular-regulated protein kinase (ERK), proline (P) for  
c-Jun NH2-terminal kinase (JNK) and glycine (G) for p38  
MAPK. Abbreviations: ASK, apoptosis signal-regulating kinase;  
ATF2, activating transcription factor-2; C/EBP, CCAAT/enhancer- 
binding protein; CHOP, C/EBP-homologous protein; map, mitogen- 
activated protein; MAPKAPK, MAPK activated protein kinase;  
MBP, myelin basic protein; MEF2C, myocyte enhancer factor 2C;  
EK, MAPK or ERK kinase; MEKK, MEK kinase; MKK, MAPK  
kinase; MSK, mitogen- and stress-activated protein kinase 1; PAK,  
p21-activated kinase; PI3K, phosphatidylinositol 3-kinase; Sap, stress- 
activated protein; SKK, stress-activated protein kinase kinase; STMR,  
seven transmembrane receptor; TAK, transforming growth factor b  
(TGF-b-activating kinase); TKR, tyrosine kinase receptor; TNFR,  
tumour necrosis factor receptor; TRAF, TNFR-associated factor.  
Figure was acquired from Herlaar and Brown, 1999         50     
 
4.1 Physiological effects of NO and reactive nitrogen species (RNS).  
Figure was adapted from Grisham et al. (1999)                    100 
 
4.2 Chemical pathway of the Griess Reagents (acquired from author?  
product manual of Nitrate/Nitrite Colorimetric Assay Kit using  
Lactate Dehydrogenase Method, Cayman Chemical)         111 
 
4.3 Effect of IFN-γ and LPS-induced NO production in murine  
monocytic macrophage cell lines (RAW 264.7). Cells  
(5 x 104 cells/well) were stimulated with LPS (0.1, 1 and 10 μg/ml)  
at various combination concentration of IFN-γ (2, 20 and 200 U/ml)  
and C; basal concentrations of NO2-. The amount of NO2- released  
by RAW 264.7 cells was measured after 17-20 hours of incubation  
by the Griess method. The data are expressed as means in triplicates  
from single experiment (n=1)            86  
 
4.4 Effect of IFN-γ/LPS-induced NO production on RAW 264.7 cells  
viability. C; RAW 264.7 cells without inducers. The data are  
expressed as means in triplicates from single experiment (n=1)       87 
 
4.5 A) Graph line above shows the effect of NO productions and RAW  
264. 7 cells viability after treated with L-NAME (7.81-1000 μM),  
 xxiii
a NOS inhibitor (n=1). B) Bar graph shows the effect of IFN-γ/LPS  
on NO productions with or without 0.1% DMSO and L-NAME at  
selected concentration of 250 μM as a drug control. The data  
represent the mean ± S.E.M. (n=3). **P<0.01 significantly different  
from the induced with DMSO           89 
 
4.6 Microscopy examination above show RAW 264.7 macrophage cells  
were adherent to plastic and were randomly distributed in culture  
media at >90% confluency (320X digital magnification).  
A) Uninduced RAW 264.7 cells. The resting macrophages were  
predominantly spherical or irregular. The cytoplasmatic membranes  
were intact and the cytoplasms homogeneous presenting small  
vacuoles. According to Asfora et al. (2005), a healthy macrophage  
is characterized with a kidney-form centralized nucleous, with  
chromatin loosely distributed and intact nuclear membrane.  
B) RAW 264.7 cells after induced by IFN-γ/LPS with 0.1% DMSO  
C) RAW 264.7 cells after induced by IFN-γ/LPS without 0.1%  
DMSO D) RAW 264.7 cells after treatment with 250 μM of NOS  
inhibitor, L-NAME. As shown in the pictures above, both induced  
and treated RAW 264.7 cells had undergo a remarkable  
morphological transformation from macrophage-like cells into  
dendritic-like cells. Dendritic morphology is characterized by  
multiple prominent cytoplasmic processes, larger nuclei, prominent  
nucleoli and relatively prominent cytoplasm with increased  
granularity (Raxena et al., 2003). IFN-γ/LPS-treated RAW 264.7  
cells also dramatically increased in size          90  
 
4.6       Microscopy examination of RAW 264.7 macrophage cells (320X  
digital magnification). E) The MTT formazan produced by live cells  
appear as black, fuzzy crystals. F) The dead macrophages appeared  
deformed and agglomerated. The cytoplasmatic membranes were  
disrupted in practically all the cells and the cytoplasm of each  
macrophage was dense with big vacuoles in some areas. According  
to Asfora et al. (2005), the nucleus of dead macrophages was more  
peripheral and the disruption of the nuclear membrane was  
conspicuous. The chromatin was dense and no extracellular  
granulation was observed            91  
 
4.7 Structure of chalcone             97 
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